Assessment of the penile vascular system with color-coded duplex sonography and pharmacocavernosometry and -graphy in impotent men. 1997

R Andresen, and H E Wegner
Department of Radiology and Nuclear Medicine, Behring Municipal Hospital, Free University of Berlin, Germany.

OBJECTIVE To examine the extent to which color-coded duplex sonography permits complete clarification of vessel-dependent erectile dysfunction (ED). METHODS A total of 215 patients with ED were examined. All patients underwent pharmacocolor-coded duplex sonography (PHCCDS; 20 micrograms of prostaglandin E1, PGE1, intracavernosally) as well as pharmacocavernosometry and -graphy (PHCM and PHCG; 20 micrograms of PGE1 intracavernosally). The penile vessels were visualized, i.e. the dorsal arteries, the cavernosal arteries, and the anastomoses between them, as well as the venous pathways. Peak flow and end-diastolic flow in all arteries and, when present, anastomoses were determined after stimulation. Induction flow to achieve maximal tumescence/rigidity as well as maintenance flow were determined during PHCM. Finally, for the morphological visualization of the cavenous body and possible venous insufficiencies, a radiography in 2 planes was produced with infusion of a water-soluble contrast medium. RESULTS In 145 patients with a grade 0-III tumescence after stimulation with 20 micrograms of PGE1, PHCCDS revealed an end-diastolic flow of > 5 cm/s, with a peak flow velocity > 25 cm/s in the 2 cavernosal and 2 dorsal arteries. The deep dorsal vein of the penis was visualized in 110 of these 145 patients with a blood flow > 5 cm/s, and in 35 cases with a blood flow < 5 cm/s. Venous drainage to the corpus spongiosum was visualized in 80 patients with a blood flow > 10 cm/s. All patients had a pathologically increased induction (normal value < 100 ml/min) and maintenance venous flow (normal value < 10 ml/min) in the PHCM as well as venous drainage in the PHCG. Sixty patients with a tumescence grade of IV-V (rigidity) had a peak flow velocity clearly > 25 cm/s, an end-diastolic flow < 5 cm/s in the 2 cavernosal and 2 dorsal arteries in the PHCCDS, as well as induction values < 100 ml/min and maintenance flow values < 10 ml/min in the PHCM, without visible insufficient efferent venous pathways on the PHCG. In 29 patients (13.5%) hemodynamically active anastomoses perforating the tunica albuginea could be detected. Ten patients with a tumescence grade of III had a peak flow velocity < 25 cm/s and an end-diastolic flow < 5 cm/s without venous leakage in PHCM and PHCG. CONCLUSIONS PHCCDS allows for the assessment of arterial flow disorder as well as of venous leakage in ED. PHCM and PHCG should only be carried out in patients in whom surgical or radiological interventional procedures at the efferent venous pathways are planned.

UI MeSH Term Description Entries
D008297 Male Males
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D014463 Ultrasonography The visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz. Echography,Echotomography,Echotomography, Computer,Sonography, Medical,Tomography, Ultrasonic,Ultrasonic Diagnosis,Ultrasonic Imaging,Ultrasonographic Imaging,Computer Echotomography,Diagnosis, Ultrasonic,Diagnostic Ultrasound,Ultrasonic Tomography,Ultrasound Imaging,Diagnoses, Ultrasonic,Diagnostic Ultrasounds,Imaging, Ultrasonic,Imaging, Ultrasonographic,Imaging, Ultrasound,Imagings, Ultrasonographic,Imagings, Ultrasound,Medical Sonography,Ultrasonic Diagnoses,Ultrasonographic Imagings,Ultrasound, Diagnostic,Ultrasounds, Diagnostic
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D018783 Impotence, Vasculogenic Inability to achieve and maintain an erection (ERECTILE DYSFUNCTION) due to defects in the arterial blood flow to the PENIS, defect in venous occlusive function allowing blood drainage (leakage) from the erectile tissue (corpus cavernosum penis), or both. Impotence, Arteriogenic,Impotence, Venogenic,Venous Leakage, Penile,Arteriogenic Impotence,Leakage, Penile Venous,Penile Venous Leakage,Vasculogenic Impotence,Venogenic Impotence

Related Publications

R Andresen, and H E Wegner
April 1996, The Journal of urology,
R Andresen, and H E Wegner
July 1992, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
R Andresen, and H E Wegner
January 1993, Scandinavian journal of urology and nephrology,
R Andresen, and H E Wegner
March 1990, Deutsche medizinische Wochenschrift (1946),
R Andresen, and H E Wegner
July 1991, Aktuelle Radiologie,
R Andresen, and H E Wegner
August 1999, Journal of neurology,
R Andresen, and H E Wegner
September 1992, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
R Andresen, and H E Wegner
April 1991, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Copied contents to your clipboard!